| 000 | 01698 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516075117.0 | ||
| 264 | 0 | _c20120625 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1549-490X | ||
| 024 | 7 |
_a10.1634/theoncologist.2011-0321 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSaylor, Philip J | |
| 245 | 0 | 0 |
_aChanges in biomarkers of inflammation and angiogenesis during androgen deprivation therapy for prostate cancer. _h[electronic resource] |
| 260 |
_bThe oncologist _c2012 |
||
| 300 |
_a212-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAndrogen Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 |
_aChemokine CXCL12 _xblood |
| 650 | 0 | 4 |
_aFibroblast Growth Factor 2 _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation _xblood |
| 650 | 0 | 4 |
_aInterleukin-1beta _xblood |
| 650 | 0 | 4 |
_aInterleukin-6 _xblood |
| 650 | 0 | 4 |
_aInterleukin-8 _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeovascularization, Physiologic |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xblood |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xblood |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-1 _xblood |
| 700 | 1 | _aKozak, Kevin R | |
| 700 | 1 | _aSmith, Matthew R | |
| 700 | 1 | _aAncukiewicz, Marek A | |
| 700 | 1 | _aEfstathiou, Jason A | |
| 700 | 1 | _aZietman, Anthony L | |
| 700 | 1 | _aJain, Rakesh K | |
| 700 | 1 | _aDuda, Dan G | |
| 773 | 0 |
_tThe oncologist _gvol. 17 _gno. 2 _gp. 212-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1634/theoncologist.2011-0321 _zAvailable from publisher's website |
| 999 |
_c21514913 _d21514913 |
||